Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Deficit) (Details Narrative)

v3.23.2
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Jun. 30, 2023
Feb. 10, 2023
Aug. 15, 2022
Jun. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Offering price for common stock         $ 1,945,677 $ 14,515,968 $ 4,452,012        
Number of shares sold         0            
Proceeds from sale of common stock                 $ 21,024,070  
Private warrants expired                 7,549    
Series B Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Net share settlement of warrants, shares                 3,026    
Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Offering price for common stock         $ 366 $ 1,226 $ 242        
Sale of common stock, net of issuance costs, shares         3,660,000 12,255,830 2,416,487        
Net share settlement of warrants, shares         11,194,493 231,481 3,026        
Common Stock [Member] | Series B Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of common stock, net of issuance costs, shares                 3,026    
Prefunded Warrant [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of common stock, net of issuance costs, shares         3,036,000       3,036,000    
Warrants exercised         3,036,000       3,036,000    
Common Stock Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of common stock, net of issuance costs, shares         11,194,493       11,425,974    
Net share settlement of warrants, shares         21,861,332       22,324,294    
Chardan Capital Markets LLC [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of common stock, net of issuance costs, shares 3,660,000                    
Purchase of warrants 5,000,000     5,000,000 5,000,000     5,000,000 5,000,000    
Exercisable price $ 0.45     $ 0.45 $ 0.45     $ 0.45 $ 0.45    
Proceeds from issuance of private placement       $ 2,300,000       $ 1,900,000      
2022 Sales Agreement [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Offering price for common stock     $ 7,800,000                
Gross proceeds from sale agreement   $ 15,000,000.0                  
Proceeds from sale of common stock   $ 13,600,000                  
2022 Sales Agreement [Member] | Underwriter Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Purchase of warrants 150,000 972,222   150,000 150,000     150,000 150,000    
Exercisable price   $ 1.35                  
2022 Sales Agreement [Member] | Underwriter Warrants [Member] | Forecast [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercisable price                     $ 0.6749
2022 Sales Agreement [Member] | Common Stock [Member] | Investors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of common stock, net of issuance costs, shares   11,664,888                  
2022 Sales Agreement [Member] | Prefunded Warrant [Member] | Investors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Purchase of warrants   2,224,000                  
Exercisable price   $ 0.0001                  
Share price   $ 1.0799                  
2022 Sales Agreement [Member] | Prefunded Warrant [Member] | Chardan Capital Markets LLC [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Purchase of warrants 1,340,000     1,340,000 1,340,000     1,340,000 1,340,000    
2022 Sales Agreement [Member] | Common Warrant [Member] | Investors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Purchase of warrants   27,777,776                  
Exercisable price   $ 1.08                  
2022 Sales Agreement [Member] | Common Warrant [Member] | Chardan Capital Markets LLC [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercisable price $ 0.0001     $ 0.0001 $ 0.0001     $ 0.0001 $ 0.0001    
2022 Sales Agreement [Member] | Common Warrant [Member] | Chardan Capital Markets LLC [Member] | Forecast [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercisable price                     $ 0.6749
2022 Sales Agreement [Member] | BTIG LLC [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Offering price for common stock     $ 25,000,000.0                
Number of shares sold                 3,007,429    
Gross proceeds from sale agreement                 $ 5,800,000    
Proceeds from sale of common stock                 $ 5,400,000